Načítá se...
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
BACKGROUND: Symptoms of anxiety and depression are common in inflammatory bowel disease (IBD). Antidepressants are taken by approximately 30% of people with IBD. However, there are no current guidelines on treating co‐morbid anxiety and depression in people with IBD with antidepressants, nor are the...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459769/ https://ncbi.nlm.nih.gov/pubmed/30977111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012680.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|